Insecticides allow control of agricultural pests and disease vectors and are vital for global 22 food security and health. The evolution of resistance to insecticides, such as 23 organophosphates (OPs), is a serious and growing concern. OP resistance often involves 24 sequestration or hydrolysis of OPs by carboxylesterases. Inhibiting carboxylesterases could 25 therefore restore the effectiveness of OPs for which resistance has evolved. Here, we use 26 covalent computational design to produce nano/pico-molar boronic acid inhibitors of the 27 carboxylesterase aE7 from the agricultural pest Lucilia cuprina, as well as a common 28 Gly137Asp aE7 mutant that confers OP resistance. These inhibitors, with high selectivity 29 against human acetylcholinesterase, and low to no toxicity in human cells and mice, act 30 synergistically with the OPs diazinon and malathion to reduce the amount of OP required to 31 kill L. cuprina by up to 16-fold, and abolish resistance. The compounds exhibit broad utility in 32 significantly potentiating another OP, chlorpyrifos against the common pest, the peach-
LcαE7 catalyzes the hydrolysis of fatty acid substrates via the canonical serine hydrolase 4 mechanism 18,25 . Boronic acids are known to form reversible covalent adducts with the 5 catalytic serine of serine hydrolases, which mimic the geometry of the transition state for 6 carboxylester hydrolysis and therefore bind with high affinity 26 . We used DOCKovalent, an 7 algorithm for screening covalent inhibitors, to screen a library of ~23,000 boronic acids 8 against the crystal structure of LcαE7 (PDB code 4FNG). Each boronic acid was modelled 9 as a tetrahedral species covalently attached to the catalytic serine (Ser218) 10 ( Supplementary Fig. 1) . After applying the covalent docking protocol, the top 2% of the 11 ranked library was manually examined, and five compounds ranked between 8 and 478 12 were selected for testing ( Fig. 2) . exhibited Ki values lower than 12 nM (Fig. 2, Supplementary Fig. 2) , with the most potent 
23
Crystallography validates docking pose predictions 24 We solved the co-crystal structures of compounds 1 to 5 with LcαE7 to assess the binding 25 poses predicted by DOCKovalent ( Fig. 2, Supplementary Table 1 ). Difference electron 26 density maps show the boronic acid compounds covalently bound to the catalytic serine 27 (Fig. 2) . The fit of the boronic acids to the active site varies with substitution pattern; the 3,5-28 disubstitution of compound 3 is highly complementary while the 3,4-disubstitution of the 29 remaining compounds results in a sub-optimal fit (Fig. 2, Supplementary Fig. 3) . The co-30 crystal structure of compound 3 reveals an unexpected trigonal planar adduct rather than the 31 typical tetrahedral adduct 27 (Supplementary Fig. 4 ).
33
Comparison between the various co-crystal structures and the docked poses largely 34 validates the DOCKovalent predictions (Fig. 2) . Compounds 3 and 5 were accurately 35 predicted with root mean square deviation (RMSD) of only 1.11 Å and 1.61 Å respectively.
36
Docking predicted a flipped orientation of compound 1 with respect to the bromine 37 5 substituent (RMSD 2.04 Å). For compound 2, the prediction of the benzyloxy substituent was 1 not accurate (RMSD 3.01 Å). Finally, the naphthalene ring of 4 was flipped relative to the 2 docking prediction (RMSD 2.02 Å) which required a change in conformation of Met308 3 ( Supplementary Fig. 3 
19
Gly137Asp mutation is located in the oxyanion hole and positions a new general base to 20 catalyze dephosphorylation of the catalytic serine 15,28 . Thus, compounds that inhibit WT 21 LcαE7 as well as this common resistance associated variant would increase the efficacy of
22
OPs by targeting both detoxification routes. Encouraged by the activity of the boronic acids 1 23 to 5, we tested the compounds against the Gly137Asp variant of LcαE7 (Fig. 2 To improve Gly137Asp inhibition while maintaining good WT potency, we focused on 2 elaborating compound 3, the most potent WT inhibitor. We purchased 12 commercially 3 available analogues of 3-bromo phenylboronic (Fig. 3) . These compounds were chosen 4 because they share the 3,5-disubsitution and include small and/or flexible substituents at the 5 5 position. We determined Ki values for WT and Gly137Asp LcαE7, and, while we did not 6 find a more potent inhibitor of WT LcαE7, six of the 12 analogs exhibited picomolar Ki values 7 ( Fig. 3, Supplementary Fig. 2 and 5) . This establishes a stable structure-activity 8 relationship between the 3,5-disubstituted phenylboronic acid and high affinity WT LcαE7 9 binding. Importantly, analogs 3.9 and 3.10, which possess the 3,5-disubstitution pattern and 10 a benzyloxy or phenoxy substituent, exhibited a 4.4-and 6.1-fold improvement in inhibition 11 of Gly137Asp LcαE7 respectively, compared to compound 3.
13
To investigate the binding of the most potent inhibitor of Gly137Asp LcαE7, compound 3.10,
14
we determined its co-crystal structure to 1.75 Å ( Supplementary Table 1 Fig. 6 ). The active site has undergone a reorganization,
18
with the Asp137, Phe309 and Tyr457 side-chains adopting alternative conformations 19 compared to the apo enzyme ( Fig. 3) . The reorganization allowed the Asp137 side-chain to 20 avoid a steric clash with the phenoxy substituent. Surprisingly, compound 3.10 adopts a 21 tetrahedral geometry rather than the trigonal planar geometry observed for compound 3
22
( Supplementary Fig. 6 ). 
10
Selectivity against human hydrolases
11
To characterize selectivity against human cholinesterases, compounds 1-5 and 3.9-3.10 12 were assayed against human AChE and the related blood plasma enzyme 13 butyrylcholinesterase (BChE) ( Fig. 4 and Supplementary Fig. 7) . The most promising 14 compounds with respect to LcαE7 inhibition (3, 3.9 and 3.10) were at least 20,000-fold 15 selective for WT LcαE7 over AChE. The compounds were less selective against BChE, with 16 1000-fold, 60-fold and 200-fold selectivity for compounds 3, 3.9 and 3.10 respectively. We 17 also tested the compounds against human carboxylesterase 1 and 2 (CES1 and CES2) 18 ( Fig. 4 and Supplementary Fig. 8 ). These enzymes are responsible for the majority of 19 hydrolase activity in the liver and small intestine respectively, and their substrates include 20 various xenobiotics and endogenous compounds 29 . Compounds 3, 3.9 and 3.10 were potent 21 inhibitors of CES1 with Ki values in the range of 1-4 nM ( Supplementary Table 2 Fig. 4) . Notably, the Ki values for compounds 3, 3.9 and 3.10 for CES1 and CES2 is an 2 order of magnitude less than the published IC50 values for widely used and irreversible OPs duplicate. See Supplementary Table 3 for assay conditions.
21
To explore the selectivity of the boronic acid compounds against other human serine 22 hydrolases, we performed an in-gel activity-based protein profiling (ABPP) experiment using 23 a fluorescent serine hydrolase probe and HEK293 cell lysate 31 ( Fig. 4 and Supplementary 24 Fig. 9 ). We quantified the fluorescent labelling of eight bands and found that none were 25 diminished by more than 50% when the HEK293 cell lysate was pre-treated with 100 nM of 26 any of the four compounds tested (3, 3.7, 3.9 and 3.10). We also probed the selectivity of 27 compounds 3, 3.9 and 3.10 against a panel of 26 human serine and threonine proteases 28 ( Fig. 4 and Supplementary Although the compounds demonstrate high selectivity against human AChE and a protease 7 panel ( Fig. 4) , the inhibition of CES1 and CES2 indicates that off-target interactions are 8 possible. We extended the analysis of off-target toxicity by testing the toxicity of compounds 9 1-5 and 3.9-3.10 against nine human cell lines ( Fig. 5 and Supplementary Fig. 10 and 10 Supplementary Fig. 11 ). Toxicity was assessed by the concentration of compound required 11 to reduce cell viability to 50% (IC50). The compounds were generally non-toxic except 12 against the HeLa cell line, where IC50 values were between 2 and 38 μM. Compound 2 was 13 most toxic with IC50 values less than 50 μM for five out of nine cell lines tested.
15
We next examined the general toxicity of the boronic acid compounds using a model 16 mammalian system of the C57BL/6 mouse. To assess mammalian toxicity, we evaluated the 17 effects of the compounds on mice in an acute toxicity model, in which we administered the 18 compounds at a very high dose of 300 mg/kg via oral gavage. Mice were monitored for two 19 weeks following administration, at which point surviving mice were sacrificed and autopsied 20 for assessment of internal organ damage. We tested compounds 3, 4, 3.7, 3.9 and 3.10 21 against 3-4 mice each. All mice survived and showed no clinical indication of toxicity. This
22
demonstrates very good tolerance for the phenyl boronic acids as a general class. For 23 context, the mouse LD50 of the OP chlorpyrifos is 62 mg/kg 32 and the oral LD50 for Donepezil,
24
an AChE inhibitor used clinically, is 45 mg/kg 33 . Overall, these results show that compounds 25 from this class are relatively benign to mammals at high doses and are suitable for field use. 
LcαE7 inhibitors synergistically enhance insecticides against blowfly larvae 1
We then investigated whether the boronic acid compounds could act as synergists to restore 2 the effectiveness of OP insecticides. We tested the compounds against two blowfly strains; a 3 laboratory strain (LS) which is susceptible to the OP insecticide diazinon, and the field strain 4 "Tara", which is resistant to diazinon 34 . Compound efficacy was determined by treating 5 blowfly larvae with diazinon over a range of concentrations in the presence or absence of 6 the boronic acid compounds at constant concentration, and comparing pupation 35 .
7
Compounds 2, 3, 3.9, 3.10 and 5 were selected for testing based on high potency against 8 WT and/or Gly137Asp LcαE7, and their structural diversity. We initially tested the 9 compounds by themselves and found that there was no significant difference between the fly 10 pupation rates of either blowfly strain in the presence or absence of the boronic acids 11 compounds ( Supplementary Fig. 12 ). When the susceptible strain was treated with boronic 12 acids combined with diazinon, synergism was observed for compounds 3, 3.9 and 3.10.
13
Compound 3.10 was the most effective, decreasing the amount of diazinon required to 14 achieve a 50% reduction in pupation (EC50 value) 7.3-fold compared to a diazinon only 15 control ( Fig. 6, Supplementary Fig. 13 ). We observed similar synergism when the 16 concentration of compound 3 was decreased from 1 mg/ml to 0.25 or 0.06 mg/ml 17 ( Supplementary Fig. 14) .
19
Having demonstrated synergism between the boronic acids and an OP insecticide, we 20 tested the compounds against the diazinon-resistant strain. Diazinon resistance is typically 21 associated with the Gly137Asp mutation/resistance allele. We determined the genotype of 22 the resistant strain, and found that, although the susceptible strain carried only WT alleles 23 (Gly137), the resistant strain carried both WT (Gly137) and mutant (Asp137) alleles 24 ( Supplementary Fig. 15 ). This is consistent with previous reports that duplications of the 25 chromosomal region containing αE7 have occurred, meaning that resistant strains now carry 26 copies of both WT and Gly137Asp LcαE7 36 . Resistance can be quantified by the increase in 27 the insecticide EC50. The diazinon EC50 for the resistant strain was 2.9-fold higher compared 28 to the susceptible strain ( Fig. 6) . This decrease in OP efficacy is within the range previously 29 reported for eight different blowfly strains containing the Gly137Asp mutation 37 , and is 30 sufficient to reduce OP protection in sheep from 16 weeks to 4-6 weeks 38 , and lead to failure 31 of OPs against third instar larvae 39 . When tested against the resistant strain, all the boronic 32 acids increased the efficacy of diazinon. The most effective compound (3.10) reduced the 33 EC50 12-fold. Therefore, compared to controls treated only with diazinon, compound 3.10 34 abolished the 2.9-fold resistance in the resistance strain, and rendered the resistant strain 4-
35
fold more sensitive to diazinon compared to the susceptible strain.
36 37 1 in the resistant strain with compound 3 versus compound 2 is surprising. However, this 2 discrepancy is consistent with our finding that the "Tara" strain carries both WT and 3 Gly137Asp LcαE7 alleles ( Supplementary Fig. 15 ); it has been shown that WT LcαE7 4 confers substantial OP protection to the blowfly 18 . Specifically, a compound, such as 3.10 5 that effectively inhibits both LcαE7 variants would be the best synergist against this resistant 6 strain. The synergism exhibited by compound 3.10 is therefore a function of the optimized 7 Gly137Asp LcαE7 inhibition and retention of WT LcαE7 inhibition. This highlights the 8 importance of both sequestration (via WT) and catalytic detoxification (via Gly137Asp) by 9
LcαE7 in OP resistance.
11
We also tested the effects of compounds 3, 3.9 and 3.10 on the sensitivity of the laboratory 12 strain to the OP insecticide malathion ( Fig. 6 and Supplementary Fig. 13 ). Sensitivity to 13 malathion and diazinon is qualitatively different; WT LcαE7 confers a low level of resistance 14 to diazinon via high affinity binding and slow hydrolysis, however WT LcαE7 displays 15 significant malathion hydrolysis activity of the ester linkages in the leaving group that 16 detoxifies the compound 13 . This difference is evident in the similar EC50 values for the 17 susceptible L. cuprina strain treated with malathion compared to the resistant strain treated 18 with diazinon ( Fig. 6) . Synergism with malathion was observed for all the boronic acid 19 compounds tested. Compound 3.10 was the most effective, reducing the EC50 16-fold 20 compared to a malathion only control ( Fig. 6) .
22
LcαE7 inhibitors synergize with chlorpyrifos against Myzus persicae 23
To determine the potential for broad spectrum use, we tested selected boronic acids in 24 combination with chlorpyrifos against another important agricultural pest, the peach-potato 25 aphid Myzus persicae. OP resistance in M. persicae is mediated by two overexpressed CBE 26 isozymes, E4 and FE4, which bind OPs with high affinity and act as insecticide "sponges" 40 .
27
Both E4 and FE4 are related to LcαE7 (50 and 53% amino acid similarity, respectively).
28
First, we tested the toxicity of the boronic acids in the absence of OP, which confirmed the 29 compounds have no significant toxicity by themselves ( Supplementary Fig. 16 ). We then 30 tested the efficacy of chlorpyrifos by treating adult aphids at four different concentrations, 31 equivalent to 0.7, 1.4, 2.8 and 5.6 grams per hectare (g/ha). Significant killing only occurred 32 at 5.6 g/ha (Supplementary Fig. 16 ). We then tested compounds 3.7, 3.10 and 5 (chosen 33 on the basis of their structural diversity) alongside chlorpyrifos at 2.8 and 5.6 g/ha over a 34 period of seven days (Fig. 6) . These tests showed a significant increase in the efficacy of 35 chlorpyrifos compared to the chlorpyrifos only controls (Fig. 6) . While the 2.8 g/ha 36 concentration of chlorpyrifos showed no significant killing efficacy by itself, addition of 12 compounds 3.10 and 5 resulted in almost total extermination of the aphid population, and 1 compound 3.7 resulted in ~50% killing. For the 5.6 g/ha concentration, the addition of all 2 three boronic acids results in almost full efficacy of the mixture. This significant increase in 3 chlorpyrifos efficacy, with no optimization of the compounds for M. persicae, establishes the 4 broad-spectrum potential for boronic acid compounds as a new class of insecticide synergist 5 that will allow significant reduction in the amount of OP that is required for the control of 
13
although virtual screening methods will benefit from improvements to sampling and scoring,
14
reflected by the fact that there was no correlation between docking rank and inhibitor 15 potency for the compounds from the initial screen (Fig. 2) , application of the DOCKovalent 16 method allowed the rapid identification potent inhibitors of LcαE7, with the initial testing of 17 only five compounds. The initial screen also allowed us to optimize inhibitors for the 18 Gly137Asp mutant, by combining the features of compound 3 which conferred high affinity
19
WT binding with the features of compound 2 which were tolerated by the Gly137Asp mutant 20 (Fig. 2) . Further improvements to the potency and selectivity of compounds 3.9 and 3.10 21 may be possible by modifying the benzyloxy/phenoxy substituents using medicinal 22 chemistry. Alternatively, 3-bromophenylboronic acid could be used as an "anchor" for the 23 templated in situ synthesis of new inhibitors, as has previously been described for AChE 44 .
25
A major requirement for synergists to be practical is a benign safety and environmental 26 profile. The main concern in terms of toxicity is selectivity against AChE. While the overall 27 structures of LcαE7 and human AChE are similar (PDB code 4EY4 45 , 1.05Å RMSD over 309 28 residues), structural differences in an active-site loop mean that the bromo-substituent of 29 compound 3, which is highly complementary to the LcαE7 active site, is sterically occluded 30 from the AChE active site by Phe295 (Supplementary Fig. 17 the steric clash at this position and therefore reduces selectivity (Supplementary Fig. 17 ).
6
We also found low selectivity with the boronic acid compounds for LcαE7 over 7 hCES1/hCES2. The open binding pocket of CES1 (and most likely CES2, although the 8 structure is not known) reflects its broad substrate specificity 47 and allows the active site to 9 accommodate the boronic acid compounds (Supplementary Fig. 17) . Interestingly, despite 
22
To investigate whether the boronic acids might have an unexpected toxic effect, we also 23 tested the toxicity more broadly. We showed that the compounds were selective against 24 human serine hydrolases using in-gel ABPP (Fig. 4) . We also demonstrated high selectivity 25 against a panel of 26 serine and threonine proteases ( Fig. 4) and showed that the 26 compounds have low toxicity against nine human cell lines (Fig. 5) . insecticides. Cholinergic toxicity is the main concern regarding OP insecticide use and the synergists to have broad spectrum activity against a range of insect species. This potential 20 was confirmed by the ability of the boronic acid compounds to synergize with OPs against 21 the peach-potato aphid, M. persicae (Fig. 6) . An added benefit of boronic acid synergists is 22 the potential protection from the evolution of resistance. Since boronic acids are transition 23 state analogues for the phosphorylation of the catalytic serine by OP insecticides, mutations 24 that hinder boronic acid binding will also likely disrupt OP sequestration and/or hydrolysis.
25
Despite this protection, other resistance mechanisms (although far less common than CBE-26 mediated resistance) could still render OP insecticides ineffective, such as mutations to
27
AChE that desensitize the enzyme to OPs 51 .
29
The potent and selective CBE inhibitors reported in this work represent a milestone in the 
17
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11
Receptor preparation: PDB code 4FNG was used for the docking. Ser218 was deprotonated 12 to accommodate the covalent adduct and the Oγ partial charge was adjusted to represent a 13 bonded form. His471 was represented in its doubly protonated form.
15
Sampling parameters: The covalent bond length was set to 1.5 ± 0.1 Å and the two newly 
22
Prism (Supplementary Fig. 18 ).
24
Enzyme inhibition with the boronic acid compounds was determined by assaying the initial Fig. 2 and 5) . Ki values were determined using the Cheng-Prusoff equation measuring thiocholine formation (412 nm) and the Michaelis constant was determined as 10 described previously (Supplementary Fig. 17) . Human BuChE shows substrate activation 11 at high concentrations of butyrylthiocholine 4 , hence the highest two substrate concentrations
12
(1 and 0.5 mM) were excluded for fitting the KM. determined as described previously (Supplementary Fig. 7) . 
27
were prepared in assay buffer supplemented with 0.5 mg/ml BSA. Enzyme velocity was 28 determined by measuring 4-nitrophenolate formation (405 nm) and the Michaelis constant 29 was determined as described previously (Supplementary Fig. 17 ). . Ki values were determined as described previously (Supplementary Fig. 8 
23
(MME) or PEG 550 MME. Inhibitors prepared in DMSO were incubated with protein (7 mg/ml 24 in 75 mM NaCl and 10 mM HEPES pH 7.5) to achieve a 5:1 inhibitor-to-compound 25 stoichiometric ratio. Hanging drops were set-up with 2 μl reservoir and 1 μl protein with 26 crystals forming overnight at 19°C. For cryoprotection, crystals were briefly immersed in a 27 solution containing the hanging-drop reservoir solution with the PEG concentration 28 increased to 35%, and then vitrified at 100 K in a gaseous stream of nitrogen.
30
Diffraction data was collected at 100 K on either the MX1 or MX2 beam line at the Australian
31
Synchrotron using a wavelength of 0.954 Å. Data was indexed, integrated and scaled using 32 XDS 7 . High resolution data was excluded when the correlation coefficient between random 33 half data sets (CC1/2) 8,9 decreased below 0.3 in the highest resolution shell. Phases were 34 obtained by molecular replacement with the program Phaser 10 using the coordinates of apo-
35
LcaE7-4a (PDB code 5CH3 11 ) as the search model. The initial model was improved by 36 iterative model building with COOT 12 and refinement with phenix.refine 13 . Inhibitor 37 27 coordinates and restraints were generated with eLBOW 14 . Crystallographic statistics are 1 summarized in Supplementary Table 1 .
3
To determine if the mutations present in the thermostable LcαE7-4a 5,6 influenced the 4 orientation or mode of inhibitor binding, the surface mutations present in LcαE7-4a were 5 introduced into the WT background and the protein was tested for crystallization. Two 6 mutations (Lys530Glu and Asp83Ala) were sufficient to allow crystallization in the same 7 conditions as described previously (PDB code 5TYM) (Supplementary Fig. 19 ). 
20
The effect of compounds 2, 3, 5, 3.9 and 3.10 on the development of blowfly larvae in the 21 presence of diazinon/malathion was assessed using a bioassay system in which larvae were 22 allowed to develop from the first instar stage until pupation on cotton wool impregnated with 23 diazinon/malathion over a range of concentrations, in the presence or absence of the 24 compounds at constant concentrations 17 . Each experiment utilized 50 larvae at each 25 diazinon/malathion concentration. Experiments were replicated three times for diazinon, and 26 twice for malathion. The insecticidal effects were defined by measuring the pupation rate.
27
The pupation rate dose-response data were analyzed by non-linear regression (GraphPad
28
Prism) in order to calculate EC50 values (with 95% confidence intervals) representing the 29 concentration of diazinon/malathion (alone or in combination with compounds 2, 3, 5, 3.9 or 30 3.10) required to reduce the pupation rate to 50% of that measured in control assays. The 31 effects of compounds 2, 3, 5, 3.9 and 3.10 was defined in two ways: 1) synergism ratio 32 within each isolate = the EC50 for diazinon/malathion alone / EC50 for diazinon/malathion in 33 combination with the compounds; and 2) resistance ratio = the EC50 for diazinon alone or in 34 combination with the compounds for the Tara strain / EC50 for diazinon alone with the LS
35
strain. Compounds were also tested without diazinon or malathion at 1 mg per assay. 
9
Three leaves were used for each repetition. The leaves were then air dried for 1 h at 20°C 10 until completely dry. One leaf-disc of 2.5 cm of diameter was cut in each treated leaf and 11 placed, abaxial face side up, in a Petri dish, on a thick layer of sterile water agar medium.
12
Each leaf disk was then infested with 3 adult aphids with a paint brush. Petri dishes were 13 sealed with a perforated lid with hole closed with nylon filter. One repetition comprised a
14
Petri dish with three leaf discs and 9 aphids. Four repetitions were used for each condition.
15
The petri dishes were incubated in the same controlled conditions as the breeding.
16
Assessment of living aphids was made one, three and seven days after leaf infestation.
17
Chlorpyrifos was tested at 0.7, 1.4, 2.8 and 5.6 g/ha alone or in combination with the boronic 18 acid compounds at 0.2 mg/ml. Each boronic acid compound was also tested alone at 0.2 19 mg/ml with the final concentration of DMSO at 1%. Water and 1% DMSO were used as 20 negative controls.
21

